First Bancorp’s Elevance Health ELV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$231K Sell
593
-25
-4% -$10K 0.09% 126
2026
Q2
$239K Buy
+618
New +$229K 0.09% 129
2026
Q1
– Sell
-618
Closed -$217K – 133
2025
Q4
$217K Buy
+618
New +$209K 0.12% 122
2025
Q3
– Sell
-618
Closed -$240K – 132
2025
Q2
$240K Hold
618
– – 0.14% 117
2025
Q1
$269K Hold
618
– – 0.17% 105
2024
Q4
$228K Buy
618
+25
+4% +$10.5K 0.16% 112
2024
Q3
$308K Hold
593
– – 0.21% 97
2024
Q2
$321K Hold
593
– – 0.24% 91
2024
Q1
$307K Hold
593
– – 0.23% 91
2023
Q4
$280K Hold
593
– – 0.22% 95
2023
Q3
$258K Hold
593
– – 0.23% 91
2023
Q2
$263K Hold
593
– – 0.22% 92
2023
Q1
$273K Hold
593
– – 0.23% 89
2022
Q4
$304K Hold
593
– – 0.26% 77
2022
Q3
$270K Hold
593
– – 0.24% 84
2022
Q2
$286K Hold
593
– – 0.27% 83
2022
Q1
$292K Hold
593
– – 0.27% 78
2021
Q4
$275K Buy
+593
New +$249K 0.24% 84

Other funds holding ELV

First Bancorp's ELV Position: Q3 2026 in Review

First Bancorp reduced its Elevance Health (ELV) stake by 4% in Q3 2026, selling an estimated $10K and leaving 593 shares worth $231K. The position accounts for 0.09% of the portfolio, ranked #126.

First Bancorp first reported a position in ELV in Q4 2021 and has held it in 18 quarters since. The position peaked at $321K in Q2 2024. 528 funds tracked by Wall St. Rank hold ELV as of Q3 2026.

  • First Bancorp held 593 shares of Elevance Health worth $231K as of Q3 2026.
  • First Bancorp sold 25 Elevance Health shares in Q3 2026, an estimated $10K.
  • Elevance Health made up 0.09% of First Bancorp's portfolio in Q3 2026, its #126 holding.
  • First Bancorp first reported a position in Elevance Health in Q4 2021 and has held it in 18 quarters since.
  • First Bancorp's Elevance Health position peaked at $321K in Q2 2024.
  • 528 funds tracked by Wall St. Rank held Elevance Health as of Q3 2026.

Based on First Bancorp's 13F filing for Q3 2026, filed 26 Oct 2026.